Trexquant Investment’s Amneal Pharmaceuticals AMRX Stock Holding History

Trexquant Investment’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-307,136	Closed	-$3.82M	–	1871
2026 Q1	$3.82M	Buy	+307,136	New	+$4.12M	0.03%	761
2025 Q3	–	Sell	-177,513	Closed	-$1.44M	–	1566
2025 Q2	$1.44M	Sell	177,513 -452,838	-72%	-$3.41M	0.02%	1003
2025 Q1	$5.28M	Buy	630,351 +167,631	+36%	+$1.4M	0.06%	483
2024 Q4	$3.66M	Buy	462,720 +223,158	+93%	+$1.87M	0.04%	637
2024 Q3	$1.99M	Buy	239,562 +180,104	+303%	+$1.41M	0.03%	813
2024 Q2	$378K	Sell	59,458 -174,750	-75%	-$1.11M	0.01%	1320
2024 Q1	$1.42M	Buy	234,208 +223,570	+2,102%	+$1.26M	0.03%	780
2023 Q4	$64.6K	Buy	+10,638	New	+$47.4K	﹤0.01%	1369

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Trexquant Investment's AMRX Position: Q2 2026 in Review

Trexquant Investment sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 307,136 shares — an estimated $3.82M sold.

Trexquant Investment first reported a position in AMRX in Q4 2023 and held it in 8 quarters. The position peaked at $5.28M in Q1 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Trexquant Investment reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Trexquant Investment sold 307,136 Amneal Pharmaceuticals shares in Q2 2026, an estimated $3.82M.
Trexquant Investment first reported a position in Amneal Pharmaceuticals in Q4 2023 and held it in 8 quarters.
Trexquant Investment's Amneal Pharmaceuticals position peaked at $5.28M in Q1 2025.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.